Peter Gray Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Peter Gray is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 16,068 shares of JAZZ, which is worth approximately $2 Million. The most recent transaction as insider was on Aug 14, 2023, when has been sold 1,241 shares (Ordinary Shares) at a price of $138.16 per share, resulting in proceeds of $171,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.1K

0% 3M change

0% 12M change

Total Value Held $2 Million

Peter Gray Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2023	SELL Open market or private sale	$171,456 $138.16 p/Share	1,241 Reduced 7.17%	16,068 Ordinary Shares
Aug 11 2023	BUY Grant, award, or other acquisition	-	3,075 Added 15.09%	17,309 Ordinary Shares
Aug 18 2022	SELL Open market or private sale	$1,264,000 $158.0 p/Share	8,000 Reduced 35.98%	14,234 Ordinary Shares
Aug 18 2022	BUY Exercise of conversion of derivative security	$442,240 $55.28 p/Share	8,000 Added 26.46%	22,234 Ordinary Shares
Aug 08 2022	SELL Open market or private sale	$179,585 $152.32 p/Share	1,179 Reduced 7.65%	14,234 Ordinary Shares
Aug 05 2022	BUY Grant, award, or other acquisition	-	2,561 Added 14.25%	15,413 Ordinary Shares
Aug 06 2021	SELL Open market or private sale	$209,215 $147.96 p/Share	1,414 Reduced 9.91%	12,852 Ordinary Shares
Jul 29 2021	BUY Grant, award, or other acquisition	-	2,246 Added 13.6%	14,266 Ordinary Shares

Peter Gray

Director

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account